Am J Med

1. WANG WY, Hu SC
   Mycoplasma Pneumoniae-Associated Reactive Infectious Mucocutaneous Eruption Sine Rash.
   Am J Med. 2024;137:e111-e112.
   

   >> Share

   
   

   
   Am J Trop Med Hyg

2. MEENA DS, Kumar A, Kumar D, Bohra GK, et al
   Enteric Fever-Associated Hemophagocytic Lymphohistiocytosis: A Systematic Review of Clinical Characteristics and Outcomes.
   Am J Trop Med Hyg. 2024;110:1217-1222.
   

   >> Share

   
   
3. AMBASTA A, Kusumesh R, Ali M, Bhaskar G, et al
   Causes of Vision Loss Associated with Dengue Fever in Bihar, India - A Case Series.
   Am J Trop Med Hyg. 2024;110:1172-1177.
   

   >> Share

   
   
4. CHITTRAKARN S, Siripaitoon P, Kositpantawong N, Kanchanasuwan S, et al
   Outcomes of Adjunctive Therapy with Open Arthrotomy for Patients with Septic Arthritis Due to Melioidosis: A Retrospective Study.
   Am J Trop Med Hyg. 2024;110:1223-1229.
   

   >> Share

   
   
5. GUAL-GONZALEZ L, Cantillo-Barraza O, Torres ME, Quintero-Velez JC, et al
   Antibody Seroprevalence to Spotted Fever Group Rickettsiae in Miraflores, Colombia: A Cross-Sectional Study in Humans and Dogs.
   Am J Trop Med Hyg. 2024;110:1245-1252.
   

   >> Share

   
   
6. SILVA AAO, Lima AA, Vasconcelos LCM, de Almeida RA, et al
   Performance Assessment of Treponemal and Nontreponemal Tests for the Diagnosis of Acquired Syphilis.
   Am J Trop Med Hyg. 2024;110:1237-1244.
   

   >> Share

   
   
7. SINGH H, Dhibhar DP, Selvam S, Kumar V, et al
   Unusual Iliopsoas Abscess due to Salmonella typhi.
   Am J Trop Med Hyg. 2024;110:1067-1068.
   

   >> Share

   
   
8. PINTO GV, Senthilkumar K, Rai P, Kabekkodu SP, et al
   Identification of Dominant Leptospira Serogroups among Leptospirosis Cases and Their Clinical Outcomes: A Prospective Hospital-Based Study in Mangaluru, India.
   Am J Trop Med Hyg. 2024;110:1230-1236.
   

   >> Share

   
   

   
   Antimicrob Agents Chemother

9. WALSH KF, Lee MH, Zainabadi K, Vilbrun SC, et al
   High variance in quantification of Mycobacterium tuberculosis at low bacterial loads and with differentially detectable mycobacteria.
   Antimicrob Agents Chemother. 2024 Jun 3:e0160123. doi: 10.1128/aac.01601.
   

   >> Share

   
   
10. PETERSIEL N, Giulieri S, Daniel DS, Fan S-H, et al
    Genomic investigation and clinical correlates of the in vitro beta-lactam: NaHCO(3) responsiveness phenotype among methicillin-resistant Staphylococcus aureus isolates from a randomized clinical trial.
    Antimicrob Agents Chemother. 2024 Jun 5:e0021824. doi: 10.1128/aac.00218.
    

    >> Share

    
    
11. MOTTA I, Cusinato M, Ludman AJ, Lachenal N, et al
    How much should we still worry about QTc prolongation in rifampicin-resistant tuberculosis? ECG findings from TB-PRACTECAL clinical trial.
    Antimicrob Agents Chemother. 2024 Jun 6:e0053624. doi: 10.1128/aac.00536.
    

    >> Share

    
    

    
    BMC Cancer

12. YANG L, Jiang Z, Tong J, Li N, et al
    Development and validation of a preoperative CT?based radiomics nomogram to differentiate tuberculosis granulomas from lung adenocarcinomas: an external validation study.
    BMC Cancer. 2024;24:670.
    

    >> Share

    
    

    
    BMC Pediatr

13. LI T, Li M, Feng J, Liu T, et al
    Evaluation and clinical significance of serum neurospecific enolase in children with pneumonia: a case-control study.
    BMC Pediatr. 2024;24:379.
    

    >> Share

    
    

    
    BMJ

14. MAHASE E
    UK agencies investigate E coli outbreak linked to "nationally distributed food item".
    BMJ. 2024;385:q1255.
    

    >> Share

    
    
15. JENKINSON D
    Better recognition of whooping cough in older people.
    BMJ. 2024;385:q1190.
    

    >> Share

    
    

    
    Chemotherapy

16. YIN Y, Shen K, Li H, Zhang L, et al
    Pneumocystis jirovecii Pneumonia Secondary to Blinatumomab Therapy: A Case Report.
    Chemotherapy. 2024;69:104-107.
    

    >> Share

    
    
17. DI LORENZO A, Rindi LV, Campogiani L, Imeneo A, et al
    Daptomycin-Induced Eosinophilic Pneumonia: A Case Report and Systematic Review.
    Chemotherapy. 2024;69:85-99.
    

    >> Share

    
    

    
    Clin Infect Dis

18. FOURRE N, Zimmermann V, Senn L, Monney P, et al
    Evaluation of the HANDOC score and the 2023 ISCVID and ESC Duke clinical criteria for the diagnosis of infective endocarditis among patients with streptococcal bacteremia.
    Clin Infect Dis. 2024 Jun 6:ciae315. doi: 10.1093.
    

    >> Share

    
    
19. DEQUIDT T, Boutellis J, Coussement J
    Relationship between appropriateness of empirical antibiotic therapy and mortality in patients with streptococcal bloodstream infection.
    Clin Infect Dis. 2024 Jun 6:ciae312. doi: 10.1093.
    

    >> Share

    
    
20. FOURRE N, Guery B, Papadimitriou-Olivgeris M
    Factors contributing to delayed initiation of appropriate antimicrobial treatment in patients with streptococcal bacteremia.
    Clin Infect Dis. 2024 Jun 6:ciae317. doi: 10.1093.
    

    >> Share

    
    
21. RASHITOV M, Franke M, Trevisi L, Bekbolatova G, et al
    Safety and effectiveness of three novel all-oral shortened regimens for rifampicin- or multidrug-resistant tuberculosis in Kazakhstan.
    Clin Infect Dis. 2024 Jun 4:ciae305. doi: 10.1093.
    

    >> Share

    
    
22. ABBOTT R, Landsiedel K, Atukunda M, Puryear SB, et al
    Incident Tuberculosis Infection is Associated with Alcohol use in Adults in Rural Uganda.
    Clin Infect Dis. 2024 Jun 2:ciae304. doi: 10.1093.
    

    >> Share

    
    

    
    Curr Microbiol

23. BASRANI ST, Kadam NS, Yadav DV, Patil SB, et al
    Antifungal Activity of Mefloquine Against Candida albicans Growth and Virulence Factors: Insights Into Mode of Action.
    Curr Microbiol. 2024;81:213.
    

    >> Share

    
    
24. UTHAYA KUMAR A, Ahmad Zan M, Ng CL, Chieng S, et al
    Diabetes and Infectious Diseases with a Focus on Melioidosis.
    Curr Microbiol. 2024;81:208.
    

    >> Share

    
    

    
    Eur J Clin Microbiol Infect Dis

25. HANADA S, Wajima T, Takata M, Morozumi M, et al
    Clinical manifestations and biomarkers to predict mortality risk in adults with invasive Streptococcus dysgalactiae subsp. equisimilis infections.
    Eur J Clin Microbiol Infect Dis. 2024 Jun 7. doi: 10.1007/s10096-024-04861.
    

    >> Share

    
    
26. DOU ZZ, Li W, Hu HL, Guo X, et al
    Group A Streptococcal meningitis in children: a short case series and systematic review.
    Eur J Clin Microbiol Infect Dis. 2024 Jun 6. doi: 10.1007/s10096-024-04863.
    

    >> Share

    
    

    
    Infect Immun

27. JOHNSON AO, Shipman BM, Hunt BC, Learman BS, et al
    Function and contribution of two putative Enterococcus faecalis glycosaminoglycan degrading enzymes to bacteremia and catheter-associated urinary tract infection.
    Infect Immun. 2024 Jun 6:e0019924. doi: 10.1128/iai.00199.
    

    >> Share

    
    

    
    J Antimicrob Chemother

28. BIENVENU AL, Cour M, Pavese P, Guichon C, et al
    Correlation between antifungal clinical practices and a new clinical decision support system ANTIFON-CLIC(R) for the treatment of invasive candidiasis: a retrospective multicentre study.
    J Antimicrob Chemother. 2024;79:1407-1412.
    

    >> Share

    
    
29. LIU M, Wang M, Huang M, Gao Q, et al
    Iron efflux by IetA enhances beta-lactam aztreonam resistance and is linked to oxidative stress through cellular respiration in Riemerella anatipestifer.
    J Antimicrob Chemother. 2024;79:1385-1396.
    

    >> Share

    
    
30. LEWIS R, Niazi-Ali S, McIvor A, Kanj SS, et al
    Triazole antifungal drug interactions-practical considerations for excellent prescribing.
    J Antimicrob Chemother. 2024;79:1203-1217.
    

    >> Share

    
    
31. NAVICKAITE I, Holmes H, Dondi L, Randall L, et al
    Occurrence and characterization of rmtB-harbouring Salmonella and Escherichia coli isolates from a pig farm in the UK.
    J Antimicrob Chemother. 2024;79:1329-1336.
    

    >> Share

    
    
32. KOLTE B, Nubel U
    Genetic determinants of resistance to antimicrobial therapeutics are rare in publicly available Clostridioides difficile genome sequences.
    J Antimicrob Chemother. 2024;79:1320-1328.
    

    >> Share

    
    
33. KARAKITSIOS E, Dokoumetzidis A
    Extrapolation of lung pharmacokinetics of antitubercular drugs from preclinical species to humans using PBPK modelling.
    J Antimicrob Chemother. 2024;79:1362-1371.
    

    >> Share

    
    
34. NISSIM Y, LaSala PR, Slain D
    A serial passage experiment to assess the development of resistance to ertapenem and meropenem among Enterobacterales.
    J Antimicrob Chemother. 2024;79:1463-1466.
    

    >> Share

    
    
35. WANGCHINDA W, Pogue JM, Thamlikitkul V, Leelawattanachai P, et al
    Population pharmacokinetic/pharmacodynamic target attainment analysis of IV fosfomycin for the treatment of MDR Gram-negative bacterial infections.
    J Antimicrob Chemother. 2024;79:1372-1379.
    

    >> Share

    
    
36. DURICEK M, Halmova K, Krutova M, Sykorova B, et al
    Is shorter also better in the treatment of Clostridioides difficile infection?
    J Antimicrob Chemother. 2024;79:1413-1417.
    

    >> Share

    
    
37. MARURI-ARANSOLO A, Lopez-Causape C, Hernandez-Garcia M, Garcia-Castillo M, et al
    In vitro activity of cefiderocol in Pseudomonas aeruginosa isolates from people with cystic fibrosis recovered during three multicentre studies in Spain.
    J Antimicrob Chemother. 2024;79:1432-1440.
    

    >> Share

    
    
38. GAUTHIER A, Tlili L, Battu S, Le Moan C, et al
    Sedimentation field-flow fractionation for rapid phenotypic antimicrobial susceptibility testing: a pilot study.
    J Antimicrob Chemother. 2024;79:1450-1455.
    

    >> Share

    
    
39. MOURAD A, Smith AG, Troy JD, Holland TL, et al
    Clinical outcomes in patients with piperacillin/tazobactam-non-susceptible but ceftriaxone-susceptible E. coli or K. pneumoniae bloodstream infection.
    J Antimicrob Chemother. 2024;79:1456-1461.
    

    >> Share

    
    
40. ELKAYAL O, Mertens B, Wauters J, Debaveye Y, et al
    Dosing of IV posaconazole to treat critically ill patients with invasive pulmonary aspergillosis: a population pharmacokinetics modelling and simulation study.
    J Antimicrob Chemother. 2024 Jun 3:dkae160. doi: 10.1093.
    

    >> Share

    
    
41. ALTARAWNEH H, Alhomra T, Alharbi M, Fan Y, et al
    Synergistic bactericidal activity of a novel dual beta-lactam combination against methicillin-resistant Staphylococcus aureus.
    J Antimicrob Chemother. 2024 Jun 4:dkae165. doi: 10.1093.
    

    >> Share

    
    

    
    J Biol Chem

42. KOMATH SS
    To each its own: Mechanisms of cross-talk between GPI biosynthesis and cAMP-protein kinase A signaling in Candida albicans versus Saccharomyces cerevisiae.
    J Biol Chem. 2024 Jun 3:107444. doi: 10.1016/j.jbc.2024.107444.
    

    >> Share

    
    

    
    J Clin Invest

43. BOU GHANEM EN
    CHIPing away at immunity: the role of clonal hematopoiesis of indeterminate potential in bacterial pneumonia.
    J Clin Invest. 2024;134:e181064.
    

    >> Share

    
    
44. QUIN C, DeJong EN, Cook EK, Luo YZ, et al
    Neutrophil-mediated innate immune resistance to bacterial pneumonia is dependent on Tet2 function.
    J Clin Invest. 2024;134:e171002.
    

    >> Share

    
    

    
    J Immunol

45. CAMPO M, Dill-McFarland KA, Peterson GJ, Benson B, et al
    Human Alveolar and Monocyte-Derived Human Macrophage Responses to Mycobacterium tuberculosis.
    J Immunol. 2024 Jun 5:ji2300885. doi: 10.4049/jimmunol.2300885.
    

    >> Share

    
    

    
    J Infect Dis

46. SBAA G, Delettre N, Guyonnet C, Nghia SLH, et al
    Recurrent Group B Streptococcus neonatal invasive infections, France, 2007 -2021.
    J Infect Dis. 2024 Jun 6:jiae307. doi: 10.1093.
    

    >> Share

    
    

    
    J Med Microbiol

47. MATSHEDISO GP, Durojaiye OC, Adeniyi OV
    Colistin utilization at a tertiary hospital in South Africa: an opportunity for antimicrobial stewardship practices.
    J Med Microbiol. 2024;73.
    

    >> Share

    
    
48. CURTIS A, Dobes P, Marciniak J, Hurychova J, et al
    Characterization of Aspergillus fumigatus secretome during sublethal infection of Galleria mellonella larvae.
    J Med Microbiol. 2024;73.
    

    >> Share

    
    
49. LAUMEN JGE, Van Dijck C, Manoharan-Basil SS, de Block T, et al
    The effect of daily usage of Listerine Cool Mint mouthwash on the oropharyngeal microbiome: a substudy of the PReGo trial.
    J Med Microbiol. 2024;73.
    

    >> Share

    
    

    
    J Neurosurg Pediatr

50. GUNER OZENEN G, Sahbudak Bal Z, Bolat E, Umit Z, et al
    The identification of risk factors and outcomes of cerebrospinal fluid shunt infections caused by carbapenem-resistant gram-negative bacteria in children: a retrospective cohort.
    J Neurosurg Pediatr. 2024;33:591-601.
    

    >> Share

    
    

    
    Lancet

51. ASHINZE P, Mafua N, Obafemi E
    Nigeria rolls out novel meningitis vaccine.
    Lancet. 2024;403:2373.
    

    >> Share

    
    

    
    MMWR Morb Mortal Wkly Rep

52. THOMPSON JM, Spencer K, Maass M, Rollo S, et al
    Notes from the Field: Anthrax on a Sheep Farm in Winter - Texas, December 2023-January 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:517-520.
    

    >> Share

    
    
53. VACHON MS, Barret AS, Lucidarme J, Neatherlin J, et al
    Cases of Meningococcal Disease Associated with Travel to Saudi Arabia for Umrah Pilgrimage - United States, United Kingdom, and France, 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:514-516.
    

    >> Share

    
    

    
    Pediatr Rev

54. SKAR G, Flannigan L, Latch R, Snowden J, et al
    Meningitis in Children: Still a Can't-Miss Diagnosis.
    Pediatr Rev. 2024;45:305-315.
    

    >> Share

    
    

    
    PLoS Genet

55. DAVISON C, Tallman S, de Ste-Croix M, Antonio M, et al
    Long-term evolution of Streptococcus mitis and Streptococcus pneumoniae leads to higher genetic diversity within rather than between human populations.
    PLoS Genet. 2024;20:e1011317.
    

    >> Share

    
    

    
    PLoS Med

56. LEACH AJ, Wilson N, Arrowsmith B, Beissbarth J, et al
    Hearing loss in Australian First Nations children at 6-monthly assessments from age 12 to 36 months: Secondary outcomes from randomised controlled trials of novel pneumococcal conjugate vaccine schedules.
    PLoS Med. 2024;21:e1004375.
    

    >> Share

    
    
57. OKEEFFE J, Salem-Bango L, Desjardins MR, Lantagne D, et al
    Case-area targeted interventions during a large-scale cholera epidemic: A prospective cohort study in Northeast Nigeria.
    PLoS Med. 2024;21:e1004404.
    

    >> Share

    
    

    
    PLoS One

58. PARZYGNAT JL, Crespo R, Koci MD, Dunn RR, et al
    Widespread prevalence of plasmid-mediated blaCTX-M type extended-spectrum beta-lactamase Escherichia coli in backyard broiler production systems in the United States.
    PLoS One. 2024;19:e0304599.
    

    >> Share

    
    
59. JONES AV, Manasyan A, Xue Y, Kapesa H, et al
    Benzathine penicillin G stockouts and other barriers to documented syphilis treatment in pregnancy in Zambia.
    PLoS One. 2024;19:e0304576.
    

    >> Share

    
    
60. YOVERA-ALDANA M, Sifuentes-Hermenegildo P, Cervera-Ocana MS, Mezones-Holguin E, et al
    Association of multidrug-resistant bacteria and clinical outcomes in patients with infected diabetic foot in a Peruvian hospital: A retrospective cohort analysis.
    PLoS One. 2024;19:e0299416.
    

    >> Share

    
    
61. YAN W, Xu D, Chen L, Wu X, et al
    Antimicrobial resistance and genome characteristics of Salmonella enteritidis from Huzhou, China.
    PLoS One. 2024;19:e0304621.
    

    >> Share

    
    
62. NANA SD, Duboz R, Diagbouga PS, Hendrikx P, et al
    A participatory approach to move towards a One Health surveillance system for anthrax in Burkina Faso.
    PLoS One. 2024;19:e0304872.
    

    >> Share

    
    
63. DIPPENAAR A, Costa Conceicao E, Wells F, Loubser J, et al
    Exploring the potential of Oxford Nanopore Technologies sequencing for Mycobacterium tuberculosis sequencing: An assessment of R10 flowcells and V14 chemistry.
    PLoS One. 2024;19:e0303938.
    

    >> Share

    
    
64. SHUJAT S, Shehzad W, Anjum AA, Hertl JA, et al
    Molecular identification of Coxiella burnetii in raw milk samples collected from farm animals in districts Kasur and Lahore of Punjab, Pakistan.
    PLoS One. 2024;19:e0301611.
    

    >> Share

    
    
65. ARTEMCHUK O, Evlampidou I
    Knowledge, attitudes and practices survey towards pneumococcal infection and vaccination among primary health care physicians, Ukraine, 2021.
    PLoS One. 2024;19:e0304346.
    

    >> Share

    
    
66. YU G, Xu X, Shen Y, Fang B, et al
    Diagnostic accuracy of nanopore sequencing for the rapid diagnosis of pulmonary tuberculosis: A protocol for a systematic review and meta-analysis.
    PLoS One. 2024;19:e0304162.
    

    >> Share

    
    

    
    PLoS Pathog

67. CULLUM E, Perez-Betancourt Y, Shi M, Gkika E, et al
    Deficiency in non-classical major histocompatibility class II-like molecule, H2-O confers protection against Staphylococcus aureus in mice.
    PLoS Pathog. 2024;20:e1012306.
    

    >> Share

    
    
68. DULYAYANGKUL P, Beavis T, Lee WWY, Ardagh R, et al
    Harvesting and amplifying gene cassettes confers cross-resistance to critically important antibiotics.
    PLoS Pathog. 2024;20:e1012235.
    

    >> Share

    
    
69. PAN Q, Zhang Y, Liu T, Xu Q, et al
    Mycoplasma glycine cleavage system key subunit GcvH is an apoptosis inhibitor targeting host endoplasmic reticulum.
    PLoS Pathog. 2024;20:e1012266.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share